Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 2

Status

Unknown 15Completed 10Recruiting 7Withdrawn 3Terminated 3Active not recruiting 3Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 7INDUSTRY 3

Study Type

Interventional 5Observational 2

Sponsor

Cancer Type

Gastrointestinal 7

Conditions

Breast Neoplasms 1397Neoplasms 1129Prostatic Neoplasms 744Lung Neoplasms 619Colorectal Neoplasms 596Carcinoma, Non-Small-Cell Lung 569Carcinoma, Hepatocellular 413Pancreatic Neoplasms 402Leukemia, Myeloid, Acute 398Stomach Neoplasms 355Multiple Myeloma 326Brain Neoplasms 311Ovarian Neoplasms 309Head and Neck Neoplasms 289Neoplasm Metastasis 273Precursor Cell Lymphoblastic Leukemia-Lymphoma 260Rectal Neoplasms 253Uterine Cervical Neoplasms 248Recurrence 248Melanoma 242Esophageal Neoplasms 237Glioblastoma 232Squamous Cell Carcinoma of Head and Neck 231Lymphoma 213Sarcoma 207Urinary Bladder Neoplasms 192Colonic Neoplasms 192Glioma 191Triple Negative Breast Neoplasms 188Hematologic Neoplasms 183

Interventions

mitazalimab 1irinotecan sucrosofate 1Tissue Banks 1Specimen Handling 1Magnetic Resonance Spectroscopy 1Glucose 1Genetic Testing 1Contrast Media 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Recruiting × OTHER × Pancreatic Ductal Adenocarcinoma × Clear all
NCT05296421 2026-05-04

Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer

Rutgers, The State University of New Jersey

Phase NA Recruiting
16 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT07324096 2026-03-27

AI-PACED

Mayo Clinic

Phase NA Recruiting
100 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT07199764 2026-03-06

IGNITE

University of Pennsylvania

Phase 2 Recruiting
100 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT06574620 2026-01-16

ACCELERATE

British Columbia Cancer Agency

Phase NA Recruiting
200 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT07226154 2025-11-21

PRECEPT

City of Hope Medical Center

Recruiting
200 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT06600906 2025-11-12

Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer

University of California, San Francisco

Recruiting
70 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT06467565 2024-06-21

NALIRIFOX as Induction Therapy in LAPC

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Recruiting
20 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡